These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

326 related items for PubMed ID: 18264917

  • 21. Glucocorticoids and body fat associated with renal uric acid and oxalate, but not calcium excretion, in healthy children.
    Shi L, Berkemeyer S, Buyken AE, Maser-Gluth C, Remer T.
    Metabolism; 2010 Jan; 59(1):134-9. PubMed ID: 19766265
    [Abstract] [Full Text] [Related]

  • 22. Dietary oxalate and calcium oxalate nephrolithiasis.
    Khan SR, Glenton PA, Byer KJ.
    J Urol; 2007 Nov; 178(5):2191-6. PubMed ID: 17870111
    [Abstract] [Full Text] [Related]

  • 23. Update on the medical management of stone disease.
    Tracy CR, Pearle MS.
    Curr Opin Urol; 2009 Mar; 19(2):200-4. PubMed ID: 19188774
    [Abstract] [Full Text] [Related]

  • 24. Fat malabsorption and increased intestinal oxalate absorption are common after Roux-en-Y gastric bypass surgery.
    Kumar R, Lieske JC, Collazo-Clavell ML, Sarr MG, Olson ER, Vrtiska TJ, Bergstralh EJ, Li X.
    Surgery; 2011 May; 149(5):654-61. PubMed ID: 21295813
    [Abstract] [Full Text] [Related]

  • 25. Renal tubular excretory transport of oxalate in the chicken.
    Tremaine LM, Bird JE, Quebbemann AJ.
    J Pharmacol Exp Ther; 1985 Apr; 233(1):7-11. PubMed ID: 3981463
    [Abstract] [Full Text] [Related]

  • 26. [Study of crystalluria in diabetic patients].
    Mbarki M, Jabrane J, Oussama A, Daudon M.
    Prog Urol; 2005 Jun; 15(3):420-5; discussion 425-6. PubMed ID: 16097146
    [Abstract] [Full Text] [Related]

  • 27. Food oxalate: factors affecting measurement, biological variation, and bioavailability.
    Massey LK.
    J Am Diet Assoc; 2007 Jul; 107(7):1191-4; quiz 1195-6. PubMed ID: 17604750
    [Abstract] [Full Text] [Related]

  • 28. [Metabolic syndrome and nephrolithiasis].
    Kohjimoto Y, Iba A, Sasaki Y, Hara I.
    Hinyokika Kiyo; 2011 Jan; 57(1):43-7. PubMed ID: 21304261
    [Abstract] [Full Text] [Related]

  • 29. Nephrolithiasis and intestinal disease.
    Dobbins JW.
    J Clin Gastroenterol; 1985 Feb; 7(1):21-4. PubMed ID: 3980960
    [Abstract] [Full Text] [Related]

  • 30. Urinary calculi associated with purine metabolism. Uric acid nephrolithiasis.
    Williams-Larson AW.
    Endocrinol Metab Clin North Am; 1990 Dec; 19(4):821-38. PubMed ID: 2081513
    [Abstract] [Full Text] [Related]

  • 31. A prospective study of risk factors for nephrolithiasis after Roux-en-Y gastric bypass surgery.
    Park AM, Storm DW, Fulmer BR, Still CD, Wood GC, Hartle JE.
    J Urol; 2009 Nov; 182(5):2334-9. PubMed ID: 19762043
    [Abstract] [Full Text] [Related]

  • 32. Enteric hyperoxaluria.
    Earnest DL.
    Adv Intern Med; 1979 Nov; 24():407-27. PubMed ID: 371365
    [No Abstract] [Full Text] [Related]

  • 33. Preventive treatment of calcium oxalate crystal deposition with immortal flowers.
    Orhan N, Onaran M, Şen İ, Işık Gönül İ, Aslan M.
    J Ethnopharmacol; 2015 Apr 02; 163():60-7. PubMed ID: 25617747
    [Abstract] [Full Text] [Related]

  • 34. Calcium restriction, thiazide, citrate, and allopurinol in calcium oxalate nephrolithiasis.
    Coe FL.
    Acta Urol Belg; 1994 Jun 02; 62(2):25-9. PubMed ID: 8037000
    [No Abstract] [Full Text] [Related]

  • 35. Comparative value of orange juice versus lemonade in reducing stone-forming risk.
    Odvina CV.
    Clin J Am Soc Nephrol; 2006 Nov 02; 1(6):1269-74. PubMed ID: 17699358
    [Abstract] [Full Text] [Related]

  • 36. Ascorbate conversion to oxalate in alkaline milieu and Proteus mirabilis culture.
    Hokama S, Toma C, Jahana M, Iwanaga M, Morozumi M, Hatano T, Ogawa Y.
    Mol Urol; 2000 Nov 02; 4(4):321-8. PubMed ID: 11156698
    [Abstract] [Full Text] [Related]

  • 37. Nephrolithiasis: treatment, causes, and prevention.
    Hall PM.
    Cleve Clin J Med; 2009 Oct 02; 76(10):583-91. PubMed ID: 19797458
    [Abstract] [Full Text] [Related]

  • 38. Beware the low urine pH--the major cause of the increased prevalence of nephrolithiasis in the patient with type 2 diabetes.
    Bell DS.
    Diabetes Obes Metab; 2012 Apr 02; 14(4):299-303. PubMed ID: 21992452
    [Abstract] [Full Text] [Related]

  • 39. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov 02; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 40. Metabolic syndrome and uric acid nephrolithiasis.
    Sakhaee K, Maalouf NM.
    Semin Nephrol; 2008 Mar 02; 28(2):174-80. PubMed ID: 18359398
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.